Wever, E.M.

cancer screening prostate model prostate cancer treatment mortality survival disease incidence study stage psa screening diagnosis result trial death erspc detection state population effect estimate gleason benefit reduction score european randomized study biopsy absence sensitivity chapter history progression rotterdam prostate cancer mortality prostate cancer death parameter therapy table randomized figure life-year follow-up prostate cancer screening number tumor cure rate surveillance utility patient miscan stage-shift european group control prostatectomy grade level interval onset gleason score overdiagnosi prostate-specific antigen screening quality screen antigen distribution screen-detected modeling england journal ratio lifetime radiation therapy radiation psa detection psa test int j cancer probability prostate-specific